Pfizer: Targeted Therapy in Colorectal Cancer
https://pfe-pfizercom-prod.s3.amazonaws.com/GMG_2020ONC3.pdf
 

Application Due Date: April 13, 2020

Specific Area of Interest: Projects that will be considered for Pfizer support will focus on increasing the understanding of targeted therapies including BRAF inhibitors and their use in the treatment of colorectal cancer (CRC). Topics of interest include:

• *             Prevalence of BRAF-mutated CRC
• *             Incorporating biomarkers and genomic testing into community cancer center standard practice
• *             Incorporating the use of targeted therapies into clinical practice
• *             Increasing understanding of recent clinical data to help inform the selection of treatment options
• *             Monitoring for and managing side effects of therapies
• *             Development of, or access to, patient resources to help improve patient understanding
• Of additional interest are educational initiatives that include a focus on reducing disparities in the quality of care of patients due to geographic or socio-economic factors.